Filing Flows › iSpecimen (ISPC) › Recalls, complaints & regulation
iSpecimen (ISPC): clinical trials
iSpecimen (ISPC) beyond its filings: 1 active clinical trial.
iSpecimen's latest quarter
iSpecimen, Q2 2026: revenue $152K (-79% year over year), operating margin -897.1%, net loss $1.4M, operating cash flow −$690K. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does iSpecimen have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.